Role of Serum CA125 and HE4 in Predicting Optimal Cytoreduction in Advanced Epithelial Ovarian Cancer After Neoadjuvant Chemotherapy
Crossref DOI link: https://doi.org/10.1007/s40944-023-00750-4
Published Online: 2023-08-18
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Poddar, Pabashi
Patel, Shilpa
Arora, Ruchi
Text and Data Mining valid from 2023-08-18
Version of Record valid from 2023-08-18
Article History
Received: 8 March 2023
Revised: 29 June 2023
Accepted: 23 July 2023
First Online: 18 August 2023
Declarations
:
: There is no conflict of interest.